Projects per year
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis.
Burgell, R. & Hogg, J.
9/09/19 → 31/12/24
The impact of day-time and night-time endurance exercise on gastrointestinal integrity, functional responses, symptoms, and systemic endotoxin and cytokine profiles - A laboratory controlled mechanistic exploration of circadian variation influences in ultra-endurance athletes.
4/02/19 → 31/12/19